Log In
Print
BCIQ
Print
Print this Print this
 

RGN-352

  Manage Alerts
Collapse Summary General Information
Company RegeneRx Biopharmaceuticals Inc.
DescriptionInjectable formulation of thymosin beta 4, a naturally occurring 43-amino acid peptide
Molecular Target Not applicable
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today